About charles river laboratories international inc. - CRL
Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. The Research Models and Services segment includes its insourcing solutions business and Charles River accelerator and development lab footprint. The Discovery and Safety Assessment segment offers regulatory-required safety testing of potential new drugs, vaccines, industrial and agricultural chemicals, consumer products, veterinary medicines, and medical devices. The Manufacturing Solutions segment focuses on microbial solutions and biologics solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.
CRL At a Glance
Charles River Laboratories International, Inc.
251 Ballardvale Street
Wilmington, Massachusetts 01887
| Phone | 1-781-222-6000 | Revenue | 4.02B | |
| Industry | Miscellaneous Commercial Services | Net Income | -144,338,000.00 | |
| Sector | Commercial Services | Employees | 19,700 | |
| Fiscal Year-end | 12 / 2026 | |||
| View SEC Filings |
CRL Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 2.514 |
| Price to Book Ratio | 3.167 |
| Price to Cash Flow Ratio | 13.68 |
| Enterprise Value to EBITDA | 13.662 |
| Enterprise Value to Sales | 3.127 |
| Total Debt to Enterprise Value | 0.21 |
CRL Efficiency
| Revenue/Employee | 203,826.497 |
| Income Per Employee | -7,326.802 |
| Receivables Turnover | 5.665 |
| Total Asset Turnover | 0.548 |
CRL Liquidity
| Current Ratio | 1.292 |
| Quick Ratio | 1.025 |
| Cash Ratio | 0.191 |
CRL Profitability
| Gross Margin | 30.522 |
| Operating Margin | 12.847 |
| Pretax Margin | -2.478 |
| Net Margin | -3.595 |
| Return on Assets | -1.969 |
| Return on Equity | -4.357 |
| Return on Total Capital | -2.49 |
| Return on Invested Capital | -2.422 |
CRL Capital Structure
| Total Debt to Total Equity | 83.152 |
| Total Debt to Total Capital | 45.401 |
| Total Debt to Total Assets | 36.879 |
| Long-Term Debt to Equity | 81.223 |
| Long-Term Debt to Total Capital | 44.347 |